The pandemic produced by COVID-19 has surprised almost all health and socio-economic systems worldwide with its high degree of infectivity and mortality. In short time we have learned many aspects of the epidemiology, pathophysiology and clinic of the virus responsible, SARS-Cov-2, and the disease it induces. COVID-19 is known to produce in some patients the development of an excessive immune response and hyper inflammation, damaging various organs and sometimes causing death. There is no effective treatment available at the moment, other than life support, and for this reason different revealing therapeutic options are being tested but pending confirmation of their effectiveness and safety in well-designed clinical trials. We describe the anti-inflammatory and immunomodulatory effects of Acupuncture, as well as its preclinical and clinical effectiveness in different conditions that have similar COVID-19 immunological disorders. The proven biological plausibility of Acupuncture, together with its acceptable level of clinical effectiveness and safety, make this medical technical procedure an option to try in this health emergency situation. We propose an adjusted classification of the clinical presentation of COVID-19 and an appropriate adjuvant Acupuncture protocol for each phase of the disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.